Trade Summary

2 days ago, Cox John, serving as CEO & President at Dyne Therapeutics, Inc. (DYN), sold 2,683 shares at $18.33 per share, for a total transaction value of $49,179.39. Following this transaction, Cox John now holds 368,151 shares of DYN.

This sale represents a 0.72% decrease in Cox John's stake in the company.

The trade was executed on Tuesday, June 16, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 17, 2026 at 4:07 PM ET, 1 day after the trade was made.

Dyne Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.